focus -WSS

focus

author：comprehensive 2025-09-30 00:03:40 - browse：425

Ron Wyden (left), Mike Crapo (right) -- health policy coverage from STAT — Draft legislation authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers. Pete Marovich-Pool/Getty Images

WASHINGTON — A key Senate health care panel has developed a plan to tackle reforms to middlemen in the pharmacy drug payment system, according to bill text obtained by STAT.

The draft legislation, authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho), includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers.

The most significant measure is a bill from Sens. Bob Menendez (D-N.J.) and Marsha Blackburn (R-Tenn.) that would prohibit PBMs from getting any income outside of service fees, and prohibits those service fees from being related to drugs’ list prices.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Psilocybin's anti

WSS

AstraZeneca challenges Medicare drug negotiation program

What do new weight loss drugs mean for bariatric surgery?

What do new weight loss drugs mean for bariatric surgery?

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Apellis safety probe of eye disease drug centers on injection needle

Why the world’s most expensive drug might be worth the price

leisure time

focus

hotspot

Medicare proposal to cover medical devices draws a mixed reaction

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Moonlake's readout produced a cash windfall. Risks remain

Eliminate the waiting period for sterilization covered by Medicaid

Moonlake's readout produced a cash windfall. Risks remain

Why the world’s most expensive drug might be worth the price

Medical leaders decry Supreme Court decision on affirmative action

Why more medical students aren't specializing in primary care

Apple is now the first public company to be valued at $3 trillion

Appeals court upholds limits to abortion pill

explore

How Long Island became the ‘eugenics capital of the world’

Appeals court upholds limits to abortion pill

In science, is the line between industry and academia shifting?

CDC advisory panel says seniors 'may' get RSV vaccine

Abortion pill case raises question: who can sue the FDA?

Departing Stanford president retracts two papers

hotspot

entertainment

explore

focus